Finance

Lists
300519:SHE
Zhejiang Xinguang Pharmaceutical Co Ltd
CNÂ¥14,61
+1,53%
(+0,22) 1D
16 Okt., 15:01:25 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300519...
Open
CNÂ¥14,48
High
CNÂ¥15,25
Low
CNÂ¥14,43
Mkt. cap
2,36 mjd
Avg. vol.
3,06 m
Volume
6,06 m
Dividend
2,05%
Quarterly dividend
CNÂ¥0,07
Ex-dividend date
29 Mei 2026
P/E ratio
37,69
52-wk high
CNÂ¥18,25
52-wk low
CNÂ¥11,53
EPS
CNÂ¥0,39
Shares outstanding
160,00 m
No. of employees
309
Open
CNÂ¥14,48
High
CNÂ¥15,25
Low
CNÂ¥14,43
Mkt. cap
2,36 mjd
Avg. vol.
3,06 m
Volume
6,06 m
Dividend
2,05%
Quarterly dividend
CNÂ¥0,07
Ex-dividend date
29 Mei 2026
P/E ratio
37,69
52-wk high
CNÂ¥18,25
52-wk low
CNÂ¥11,53
EPS
CNÂ¥0,39
Shares outstanding
160,00 m
No. of employees
309
News stories
From web sources and news partners
About Zhejiang Xinguang Pharmaceutical Co Ltd
CEO-
Employees309
Founded18 Nov. 1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
64,68 m
59,74 m
88,47 m
54,12 m
Cost of goods sold
35,60 m
37,97 m
48,33 m
28,36 m
Cost of revenue
35,60 m
37,97 m
48,33 m
28,36 m
Research and development expenses
3,06 m
3,31 m
2,83 m
4,05 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,41 m
10,76 m
8,04 m
8,61 m
Operating expense
10,29 m
16,44 m
11,75 m
14,24 m
Total operating expenses
45,89 m
54,41 m
60,08 m
42,60 m
Operating income
18,79 m
5,33 m
28,39 m
11,52 m
Other non operating income
-2,36 k
-2,56 k
-3,00 k
-3,63 k
EBT including unusual items
17,29 m
9,86 m
30,47 m
14,99 m
EBT excluding unusual items
19,90 m
8,11 m
30,36 m
14,33 m
Income tax expense
3,86 m
980,05 k
4,10 m
1,64 m
Effective tax rate
22,32%
9,94%
13,46%
10,97%
Other operating expenses
-251,59 k
2,61 m
1,04 m
1,38 m
Net income
13,43 m
8,88 m
26,37 m
13,34 m
Net profit margin
20,76%
14,86%
29,80%
24,65%
Earnings per share
-
-
-
-
Interest and investment income
1,12 m
2,79 m
1,98 m
2,81 m
Interest expense
-
-
-
-
Net interest expenses
1,12 m
2,79 m
1,98 m
2,81 m
Depreciation and amortization charges
-
-
-
-
EBITDA
22,52 m
9,01 m
32,07 m
14,97 m
Gain or loss from assets sale
-3,72 k
3,72 k
-
-
AI content may include mistakes. Learn more
Google-programme